Cemtromedico Latino Americano is categorized under Health Services in Houston, TX and active since 2011.
Cemtromedico Latino Americano was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Mikel Alvi, Manager at the company’s single location by writing to 14360 Bellaire Boulevard # 134, Houston, Texas TX 77083 or by phoning (281) 933-1677. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cemtromedico Latino Americano |
| Contact Person: | Mikel Alvi, Manager |
| Address: | 14360 Bellaire Boulevard # 134, Houston, Texas 77083 |
| Phone Number: | (281) 933-1677 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6214930 |
| Share This Business: |
Cemtromedico Latino Americano was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Mikel Alvi, Manager for inquiries that concern Cemtromedico Latino Americano by calling the company number (281) 933-1677, as your correspondence is most welcome. Additionally, the physical location of the single location of Cemtromedico Latino Americano can be found at the coordinates 29.704063,-95.639678 as well as the street address 14360 Bellaire Boulevard # 134 in Houston, Texas 77083.
For its online presence, you may visit Cemtromedico Latino Americano’s website at and engage with its social media outlets through on Twitter and on Facebook.